login

Year-end appeal: Please make a donation to the OEIS Foundation to support ongoing development and maintenance of the OEIS. We are now in our 61st year, we have over 378,000 sequences, and we’ve reached 11,000 citations (which often say “discovered thanks to the OEIS”).

A225857
Numbers of the form 2^i*3^j*(12k+1) or 2^i*3^j*(12k+5), i, j, k >= 0.
3
1, 2, 3, 4, 5, 6, 8, 9, 10, 12, 13, 15, 16, 17, 18, 20, 24, 25, 26, 27, 29, 30, 32, 34, 36, 37, 39, 40, 41, 45, 48, 49, 50, 51, 52, 53, 54, 58, 60, 61, 64, 65, 68, 72, 73, 74, 75, 77, 78, 80, 81, 82, 85, 87, 89, 90, 96, 97, 98, 100, 101, 102, 104, 106, 108, 109, 111
OFFSET
1,2
COMMENTS
From Peter Munn, Nov 11 2023: (Start)
Numbers k whose 5-rough part, A065330(k), is congruent to 1 modulo 4.
Contains all nonzero squares.
Positive integers in the multiplicative subgroup of rationals generated by 2, 3, 5 and integers congruent to 1 modulo 12. Thus, the sequence is closed under multiplication and, provided the result is an integer, under division.
This subgroup has index 2 and does not include -1, so is the complement of its negation. In respect of the sequence, the index 2 property implies we can take any absent positive integer m, and divide by m all terms that are multiples of m to get the complementary sequence, A225858.
Likewise, the sequence forms a subgroup of index 2 of the positive integers under the operation A059897(.,.).
(End)
The asymptotic density of this sequence is 1/2. - Amiram Eldar, Nov 14 2023
LINKS
MATHEMATICA
Select[Range[120], Mod[#/Times @@ ({2, 3}^IntegerExponent[#, {2, 3}]), 4] == 1 &] (* Amiram Eldar, Nov 14 2023 *)
PROG
(PARI) for(n=1, 200, t=n/(2^valuation(n, 2)*3^valuation(n, 3)); if((t%4==1), print1(n, ", ")))
(Magma) [n: n in [1..200] | d mod 4 eq 1 where d is n div (2^Valuation(n, 2)*3^Valuation(n, 3))]; // Bruno Berselli, May 16 2013
CROSSREFS
Complement of A225858.
Sequence in context: A176845 A196127 A194467 * A168134 A245030 A245027
KEYWORD
nonn,easy
AUTHOR
Ralf Stephan, May 18 2013
EXTENSIONS
Name clarified by Peter Munn, Nov 10 2023
STATUS
approved